Gustavo Pesquin - 06 Sep 2022 Form 3 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Officer
Signature
/s/ Jason B. Daly, as Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
3
Filing time
08 Sep 2022, 16:15:47 UTC
SEC
View on sec.gov

No securities are beneficially owned.

Remarks:

Title: Executive Vice President, Chief Commercial Officer - Specialty Exhibit List: Exhibit 24 - Power of Attorney.